$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[미국특허] Labeled liposome particle compositions and immunoassays therewith 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • G01N-031/00
  • G01N-033/16
  • G01N-023/00
  • A61K-037/00
출원번호 US-0906514 (1978-05-16)
발명자 / 주소
  • Ullman Edwin F. (Atherton CA) Brinkley John M. (Oakland CA)
출원인 / 주소
  • Syva Company (Palo Alto CA 02)
인용정보 피인용 횟수 : 151  인용 특허 : 3

초록

The subject invention concerns novel compositions for use in immunoassays, as well as immunoassays employing such novel compositions. The compositions comprise discrete charged colloidal particles comprised of small molecules which particles are capable of retaining their discrete character in an aq

대표청구항

In an immunoassay for the determination of an analyte, where the analyte is a member of a specific binding pair consisting of ligand and antiligand and wherein a label is employed which provides a detectible signal, the value of which is affected by the proximity of said antiligand to said label due

이 특허에 인용된 특허 (3) 인용/피인용 타임라인 분석

  1. Forgione Peter Salvatore (Stamford CT), Composition and method for the detection of syphilis.
  2. Ullman Edwin F. (Atherton CA) Schwarzberg Moshe (Palo Alto CA), Fluorescence quenching with immunological pairs in immunoassays.
  3. Maier ; Jr. ; Charles L., Procedure for the assay of pharmacologically immunologically and biochemically active compounds in biological fluids.

이 특허를 인용한 특허 (151) 인용/피인용 타임라인 분석

  1. DiNello Robert K. (Cupertino CA), Agglutination dependent enzyme channeling immunoassay.
  2. Janoff Andrew S. (Yardley PA) Bolcsak Lois E. (Lawrenceville NJ) Weiner Alan L. (Lawrenceville NJ) Tremblay Paul A. (Hamilton NJ) Bergamini Michael V. W. (Easton PA), Alpha tocopherol-based vesicles.
  3. Lovell Stephen J. (Towson MD) Bruton Jeffrey H. (Randallstown MD), Amplified assay for analyte.
  4. Kriksunov, Leo B; Wheelock, Geoffrey; Henderson, Lee A, Amplified bioassay.
  5. Horecka, Joseph; Fung, Peter; Eglen, Richard M., Analysis of intracellular modifications.
  6. Nilsson Kurt G. I.,SEX, Analytical reagent particle with covalently-bound enzyme.
  7. Horwitz Marcus A. ; Clemens Daniel L., Anti-microbial targeting for intracellular pathogens.
  8. Considine, John Leo; Daigneault, Sylvain; Chew, Warren; Iera, Silvio; Duncan, Scott; Ren, Jiaxen, Antineoplastic combinations.
  9. Considine, John Leo; Daigneault, Sylvain; Chew, Warren; Iera, Silvio; Duncan, Scott; Ren, Jiaxin, Antineoplastic combinations.
  10. Safar, Scott; Herchenbach, Stephen, Apparatus and method for handling fluids for analysis.
  11. Gribnau Thomas C. J. (Haren NLX) Roeles Frits (Dreumel NLX) Leuvering Johannes H. W. (Heesch NLX), Application of water-dispersible hydrophobic dyes or pigments as labels in immunoassays.
  12. Del Campo G. B. (Milan ITX), Assay for an analyte on a solid porous support.
  13. Ullman Edwin F. ; Kirakossian Hrair ; Pease John S. ; Daniloff Yuri ; Wagner Daniel B., Assay method utilizing induced luminescence.
  14. Bernstein David (Sykesville MD), Assay utilizing ATP encapsulated within liposome particles.
  15. Mirkin, Chad A.; Park, So-Jung; Nam, Jwa-Min, Bio-barcodes based on oligonucleotide-modified nanoparticles.
  16. Mirkin,Chad A.; Park,So Jung; Nam,Jwa Min, Bio-barcodes based on oligonucleotide-modified particles.
  17. Garimella,Viswanadham; Storhoff,James J., Bioconjugate-nanoparticle probes.
  18. Harris Curtis C. (8402 Thornden Ter. Bethesda MD 20034), Cascade amplification enzyme immunoassay.
  19. Papahadjopoulos Demetrios P. (Lafayette CA) Heath Timothy D. (San Francisco CA), Cell agglutination reagent comprising conjugates of antibody covalently bound to liposomes.
  20. Gibbons Ian (Menlo Park CA) Rowley Gerald L. (Cupertino CA) Ullman Edwin F. (Atherton CA), Charge effects in enzyme immunoassays.
  21. Mandle Richard M. (Pompton Lakes NJ) Wong Yuan N. (Boonton NJ), Chemical luminescence amplification substrate system for immunochemistry involving microencapsulated fluorescer.
  22. Sharat Singh ; Edwin F. Ullman, Chemiluminescent compositions for use in detection of multiple analytes.
  23. Frenzel Bernd (Spitzelbergstrasse 18a D-8000 Munich 71 DEX), Chemiluminescent immunoassay with activator of hydrogen peroxide and a chloramine.
  24. Bally Marcel B. (Vancouver CAX) Loughrey Helen (Vancouver CAX) Cullis Pieter R. (Vancouver CAX), Composition for targeting, storing and loading of liposomes.
  25. Janoff Andrew S. (Yardley PA) Bolcsak Lois E. (Lawrenceville NJ) Weiner Alan L. (Lawrenceville NJ) Tremblay Paul A. (Hamilton NJ) Bergamini Michael V. W. (Easton PA) Suddith Robert L. (Robbinsville N, Composition using salt form of organic acid derivative of alpha-tocopheral.
  26. Janoff Andrew S. (Yardley PA) Cullis Pieter R. (Vancouver CAX) Bally Marcel B. (Vancouver NJ CAX) Fountain Michael W. (Griggstown NJ) Ginsberg Richard S. (Monroe NJ) Hope Michael J. (Vancouver CAX) M, Dehydrated liposomes.
  27. Zuk Robert F. (San Francisco CA) Gibbons Ian (Menlo Park CA) Rowley Gerald L. (Cupertino CA) Ullman Edwin F. (Atherton CA), Double antibody for enhanced sensitivity in immunoassay.
  28. Gilmartin Markas A. T.,GB2, Electrodes and metallo isoindole ringed compounds.
  29. Gilmartin Markas A. T.,GB2, Electrodes and metallo isoindole ringed compounds.
  30. Sugaar Stephen (21 Louis St. Staten Island NY 10304), Encapsulated antigenic tumor specific substances and methods for detecting cancer using said substances.
  31. Gruner Sol M. (Lawrenceville NJ) Kirk Gregory (Princeton NJ), Encapsulated scintillators for measuring the concentration of tritiated solutes.
  32. Bally Marcel B.,CAX ; Cullis Pieter R.,CAX ; Hope Michael J.,CAX ; Madden Thomas D.,CAX ; Mayer Lawrence D.,CAX, Encapsulation of antineoplastic agents in liposomes.
  33. Janoff Andrew S. ; Cullis Pieter R.,CAX ; Bally Marcel B.,CAX ; Fountain Michael W. ; Ginsberg Richard S. ; Hope Michael J.,CAX ; Madden Thomas D.,CAX ; Schieren Hugh P. ; Jablonski Regina L., Encapsulation of ionizable agents in liposomes.
  34. Giese Roger W. (Quincy MA) Ehrat Markus (Suhr MA CHX) Cecchini Douglas J. (Somerville MA), Enzyme activity amplification method for increasing assay sensitivity.
  35. Liu, Yen-Ping; Ullman, Edwin F.; Becker, Martin J., Fluorescence screening for blood typing.
  36. Stryer Lubert (Stanford CA) Glazer Alexander N. (Orinda CA) Oi Vernon T. (Palo Alto CA), Fluorescent immunoassay employing a phycobiliprotein labeled ligand or receptor.
  37. Saul Tom (El Granada CA) Der-Balian Georges (Mountain View CA) Kenney Paul (Mountain View CA) Mathis Heidi (Burlingame CA) Johnson Shirley (Mountain View CA) Ribi Hans (Hillsborough CA) Witty Tom (Sa, Fluorescent lipid polymer-macromolecular ligand compositions.
  38. Zuk Robert F. (Mountain View CA) Ullman Edwin F. (Atherton CA), Fluorescent scavenger particle immunoassay.
  39. Hunt C. Anthony (San Francisco CA), Functional oxygen transport system.
  40. Lenhoff Howard M. (Costa Mesa CA) Ngo That T. (Irvine CA), Heterogeneous immunoassay method.
  41. Mayer Lawrence D. (Vancouver CAX) Bally Marcel B. (Vancouver CAX) Cullis Pieter R. (Vancouver CAX) Ginsberg Richard S. (Jamesburg NJ) Mitilenes George N. (Washington NJ), High drug:lipid formulations of liposomal antineoplastic agents.
  42. Mayer Lawrence D.,CAX ; Bally Marcel B.,CAX ; Cullis Pieter R.,CAX ; Ginsberg Richard S. ; Mitilenes George N., High drug:lipid formulations of liposomal-antineoplastic agents.
  43. Kurn Nurith (Palo Alto CA) Bahl Chander (San Mateo CA) Ullman Edwin F. (Atherton CA), Homogeneous assay for specific polynucleotides.
  44. Halfman Clarke J. (Highland Park IL), Homogeneous fluorescence ligang binding assay based upon preferential alteration of the respective intensities of bound.
  45. Elings Virgil B. (Santa Barbara CA) Nicoli David F. (Goleta CA), Homogeneous fluoroimmunoassay involving sensing radiation for forward and back directions.
  46. Popot, Jean-Luc; Charvolin, Delphine; Giusti, Fabrice, Immobilization of membrane proteins onto supports via an amphiphile.
  47. Popot, Jean-Luc; Charvolin, Delphine; Giusti, Fabrice, Immobilization of membrane proteins onto supports via an amphiphile.
  48. Cole Francis X. (Stow MA), Immunoassay products and methods.
  49. Yokoi, Masayuki; Akamine, Takayuki; Yoshikawa, Katsumi, Immunoassay reagent and immunoassay method.
  50. Cole Francis X. (Stow MA), Immunoassay with antigen or antibody labeled liposomes sequestering enzyme.
  51. Maxfield Wilson Nancy ; Larue Catherine,FRX, Immunoassays to detect antiphospholipid antibodies.
  52. Huang Leaf (352 Dominion Cir. Knoxville TN 37922) Ho Rodney J. Y. (1611 Laurel Ave. Knoxville TN 37916), Immunoliposome assay-methods and products.
  53. Adolfsen Robert H. (Montrose NY) Hedaya Eddie (Hartsdale NY) Mak C. Lam (Valley Cottage NY) Schwarzberg Moshe (Hastings-on-Hudson NY), Interference - resistant liposome specific binding assay.
  54. Fox John P. (Ardsley NY) Hedaya Eddie (Hartsdale NY) Lippman Violet (Teaneck NJ), Inverted latency specific binding assay.
  55. Farina Peter R. (North Salem NY) Golke James R. (Yorktown Heights NY), Labeled analytes.
  56. Baldeschwieler John D. (Pasadena CA) Gamble Ronald C. (Pasadena CA) Mauk Marcia R. (Vancouver NJ CAX) Shen Tsung-Ying (Westfield NJ) Ponpipom Mitree M. (Branchburg NJ), Lipid vesicles bearing carbohydrate surfaces as lymphatic directed vehicles for therapeutic and diagnostic substances.
  57. Hunt C. Anthony (San Francisco CA), Lipid-saccharide reaction products.
  58. Kawamata Masanobu (Kyoto JPX) Ushimaru Koichi (Kyoto JPX) Yamane Shuji (Kyoto JPX), Liposome and method of manufacture therefor.
  59. Haynes Lynn C. (Morris Plaines NJ) Levine Harry (Morris Plaines NJ) Finley John W. (Whippany NJ), Liposome composition for the stabilization of oxidizable substances.
  60. Papahadjopoulos Demetrios P. (Lafayette CA) Heath Timothy D. (San Francisco CA), Liposome conjugates and diagnostic methods therewith.
  61. Maxfield Wilson Nancy ; Larue Catherine,FRX, Liposome reagents for immunoassays.
  62. Szoka Frank C. (San Francisco CA), Liposomes with glycolipid-linked antibodies.
  63. Litman David J. (Palo Alto CA) Harel Zvi (Stanford CA) Ullman Edwin F. (Atherton CA), Macromolecular environment control in specific receptor assays.
  64. Litman David J. (Palo Alto CA) Harel Zvi (Stanford CA) Ullman Edwin F. (Atherton CA), Macromolecular environment control in specific receptor assays.
  65. Litman David J. (Cupertino CA) Harel Zvi (Haifa CA ILX) Ullman Edwin F. (Atherton CA), Macromolecular fluorescent quencher particle in specific receptor assays.
  66. Geho W. Blair (Wooster OH) Lau John R. (Wooster OH), Masking of liposomes from RES recognition.
  67. Lau John R. (585 King Beach Dr. Howard OH 43028) Geho W. Blair (533 Beechwood St. Wooster OH 44691), Masking of liposomes from RES recognition.
  68. Baldeschwieler John D. (Pasadena CA) Gamble Ronald C. (Pasadena CA) Mauk Marcia R. (Vancouver CAX), Means of preparation and applications of liposomes containing high concentrations of entrapped ionic species.
  69. Stuart W. Young ; Meredith Wright ; Jonathan L. Sessler ; Tarak D. Mody ; Darren Magda, Membrane incorporation of texaphyrins.
  70. Singh,Sharat; Ullman,Edwin F., Metal chelate containing compositions for use in chemiluminescent assays.
  71. Valkirs Gunars E. (San Marcos CA) Owen Newton C. (Encinitas CA) Levinson Philip A. (San Diego CA), Method and apparatus for immunoassays.
  72. Farina, Peter R.; Golke, James R., Method for carrying out non-isotopic immunoassays, labeled analytes and kits for use in such assays.
  73. Law Say-Jong (Westwood MA) Piran Uri (Sharon MA), Method for detection of an analyte using acridinium ester and liposomes.
  74. Rose Sam (San Francisco CA), Method for isolating product-producing cells.
  75. Pease John S. (Los Altos CA) Kirakossian Hrair (San Jose CA) Wagner Daniel B. (Sunnyvale CA) Ullman Edwin F. (Atherton CA), Method of calibration with photoactivatable chemiluminescent matrices.
  76. Janoff Andrew S. (Yardley PA) Cullis Pieter R. (Vancouver CAX) Bally Marcel B. (Vancouver CAX) Fountain Michael W. (Griggstown NJ) Ginsberg Richard S. (Monroe NJ) Hope Michael J. (Vancouver CAX) Madd, Method of dehydrating liposomes using protective sugars.
  77. Letsinger, Robert L.; Garimella, Viswanadham, Method of detection by enhancement of silver staining.
  78. Sobek Andrew A. (Fairlawn OH) Reutern Eric (Marietta OH) Pausch Jerry B. (Northfield OH), Method of making and a slow release composition for abating acid water formation.
  79. Schmidt Paul G. ; Fujii Gary, Method of making liposomes with improved stability during drying.
  80. Presant Cary A. ; Proffitt Richard T. ; Teplitz Raymond L. ; Williams Lawrence E. ; Tin George W., Method of targeting a specific location in a body using phospholipid and cholesterol liposomes which encapsulate an agent.
  81. Indriksons Andris ; Andrews Patricia C., Methods and apparatus using hydrogels.
  82. Henderson Daniel R. (Benicia CA), Methods for protein binding enzyme complementation assays.
  83. Janoff Andrew S. ; Cullis Pieter R.,CAX ; Bally Marcel B.,CAX ; Fountain Michael W. ; Ginsberg Richard S. ; Hope Michael J.,CAX ; Madden Thomas D.,CAX ; Schieren Hugh P. ; Jablonski Regina L., Methods of dehydrating, storing and rehydrating liposomes.
  84. Mayer Lawrence D.,CAX ; Bally Marcel B.,CAX ; Cullis Pieter R.,CAX ; Ginsberg Richard S. ; Mitilenes George N., Methods of treatment using high drug-lipid formulations of liposomal-antineoplastic agents.
  85. Kakimi Fujio (Shizuoka JPX) Matsukawa Hiroharu (Shizuoka JPX) Akiyoshi Yutaka (Tokyo JPX) Kobayashi Shinzo (Tokyo JPX), Microcapsules for immune response.
  86. Storhoff,James J.; Letsinger,Robert L.; Hagenow,Susan R., Nanoparticle polyanion conjugates and methods of use thereof in detecting analytes.
  87. Mirkin, Chad A.; Cao, Yunwei; Jin, Rongchao, Nanoparticle probes with raman spectroscopic fingerprints for analyte detection.
  88. Chad A. Mirkin ; Robert L. Letsinger ; Robert C. Mucic ; James J. Storhoff ; Robert Elghanian, Nanoparticles having oligonucleotides attached thereto and uses therefor.
  89. Chad A. Mirkin ; Robert L. Letsinger ; Robert C. Mucic ; James J. Storhoff ; Robert Elghanian, Nanoparticles having oligonucleotides attached thereto and uses therefor.
  90. Chad A. Mirkin ; Robert L. Letsinger ; Robert C. Mucic ; James J. Storhoff ; Robert Elghanian, Nanoparticles having oligonucleotides attached thereto and uses therefor.
  91. Mirkin, Chad A.; Letsinger, Robert L.; Mucic, Robert C.; Storhoff, James J.; Elghanian, Robert; Taton, Thomas A., Nanoparticles having oligonucleotides attached thereto and uses therefor.
  92. Mirkin, Chad A.; Letsinger, Robert L.; Mucic, Robert C.; Storhoff, James J.; Elghanian, Robert; Taton, Thomas A., Nanoparticles having oligonucleotides attached thereto and uses therefor.
  93. Mirkin, Chad A.; Letsinger, Robert L.; Mucic, Robert C.; Storhoff, James J.; Elghanian, Robert; Taton, Thomas A., Nanoparticles having oligonucleotides attached thereto and uses therefor.
  94. Mirkin, Chad A.; Letsinger, Robert L.; Mucic, Robert C.; Storhoff, James J.; Elghanian, Robert; Taton, Thomas A., Nanoparticles having oligonucleotides attached thereto and uses therefor.
  95. Mirkin, Chad A.; Letsinger, Robert L.; Mucic, Robert C.; Storhoff, James J.; Elghanian, Robert; Taton, Thomas A., Nanoparticles having oligonucleotides attached thereto and uses therefor.
  96. Mirkin, Chad A.; Letsinger, Robert L.; Mucic, Robert C.; Storhoff, James J.; Elghanian, Robert; Taton, Thomas A., Nanoparticles having oligonucleotides attached thereto and uses therefor.
  97. Mirkin, Chad A.; Letsinger, Robert L.; Mucic, Robert C.; Storhoff, James J.; Elghanian, Robert; Taton, Thomas A., Nanoparticles having oligonucleotides attached thereto and uses therefor.
  98. Mirkin, Chad A.; Letsinger, Robert L.; Mucic, Robert C.; Storhoff, James J.; Elghanian, Robert; Taton, Thomas A., Nanoparticles having oligonucleotides attached thereto and uses therefor.
  99. Mirkin, Chad A.; Letsinger, Robert L.; Mucic, Robert C.; Storhoff, James J.; Elghanian, Robert; Taton, Thomas A., Nanoparticles having oligonucleotides attached thereto and uses therefor.
  100. Mirkin, Chad A.; Letsinger, Robert L.; Mucic, Robert C.; Storhoff, James J.; Elghanian, Robert; Taton, Thomas A., Nanoparticles having oligonucleotides attached thereto and uses therefor.
  101. Mirkin, Chad A.; Letsinger, Robert L.; Mucic, Robert C.; Storhoff, James J.; Elghanian, Robert; Taton, Thomas A., Nanoparticles having oligonucleotides attached thereto and uses therefor.
  102. Mirkin, Chad A.; Letsinger, Robert L.; Mucic, Robert C.; Storhoff, James J.; Elghanian, Robert; Taton, Thomas A., Nanoparticles having oligonucleotides attached thereto and uses therefor.
  103. Mirkin, Chad A.; Letsinger, Robert L.; Mucic, Robert C.; Storhoff, James J.; Elghanian, Robert; Taton, Thomas A., Nanoparticles having oligonucleotides attached thereto and uses therefor.
  104. Mirkin, Chad A.; Letsinger, Robert L.; Mucic, Robert C.; Storhoff, James J.; Elghanian, Robert; Taton, Thomas A., Nanoparticles having oligonucleotides attached thereto and uses therefor.
  105. Mirkin, Chad A.; Letsinger, Robert L.; Mucic, Robert C.; Storhoff, James J.; Elghanian, Robert; Taton, Thomas A., Nanoparticles having oligonucleotides attached thereto and uses therefor.
  106. Mirkin, Chad A.; Letsinger, Robert L.; Mucic, Robert C.; Storhoff, James J.; Elghanian, Robert; Taton, Thomas A., Nanoparticles having oligonucleotides attached thereto and uses therefor.
  107. Mirkin, Chad A.; Letsinger, Robert L.; Mucic, Robert C.; Storhoff, James J.; Elghanian, Robert; Taton, Thomas A., Nanoparticles having oligonucleotides attached thereto and uses therefor.
  108. Mirkin, Chad A.; Letsinger, Robert L.; Mucic, Robert C.; Storhoff, James J.; Elghanian, Robert; Taton, Thomas A., Nanoparticles having oligonucleotides attached thereto and uses therefor.
  109. Mirkin, Chad A.; Letsinger, Robert L.; Mucic, Robert C.; Storhoff, James J.; Elghanian, Robert; Taton, Thomas A., Nanoparticles having oligonucleotides attached thereto and uses therefor.
  110. Mirkin, Chad A.; Letsinger, Robert L.; Mucic, Robert C.; Storhoff, James J.; Elghanian, Robert; Taton, Thomas A., Nanoparticles having oligonucleotides attached thereto and uses therefor.
  111. Mirkin, Chad A.; Letsinger, Robert L.; Mucic, Robert C.; Storhoff, James J.; Elghanian, Robert; Taton, Thomas A., Nanoparticles having oligonucleotides attached thereto and uses therefor.
  112. Mirkin, Chad A.; Letsinger, Robert L.; Mucic, Robert C.; Storhoff, James J.; Elghanian, Robert; Taton, Thomas A., Nanoparticles having oligonucleotides attached thereto and uses therefor.
  113. Mirkin, Chad A.; Letsinger, Robert L.; Mucic, Robert C.; Storhoff, James J.; Elghanian, Robert; Taton, Thomas A., Nanoparticles having oligonucleotides attached thereto and uses therefor.
  114. Mirkin, Chad A.; Letsinger, Robert L.; Mucic, Robert C.; Storhoff, James J.; Elghanian, Robert; Taton, Thomas A.; Garimella, Viswanadham; Li, Zhi, Nanoparticles having oligonucleotides attached thereto and uses therefor.
  115. Mirkin, Chad A.; Letsinger, Robert L.; Park, So-Jung, Nanoparticles having oligonucleotides attached thereto and uses therefor.
  116. Mirkin,Chad A.; Letsinger,Robert L.; Li,Zhi, Nanoparticles having oligonucleotides attached thereto and uses therefor.
  117. Mirkin,Chad A.; Letsinger,Robert L.; Mucic,Robert C.; Storhoff,James J.; Elghanian,Robert; Taton,Thomas A., Nanoparticles having oligonucleotides attached thereto and uses therefor.
  118. Mirkin,Chad A.; Letsinger,Robert L.; Mucic,Robert C.; Storhoff,James J.; Elghanian,Robert; Taton,Thomas Andrew, Nanoparticles having oligonucleotides attached thereto and uses therefor.
  119. Mirkin,Chad A.; Letsinger,Robert L.; Mucic,Robert C.; Storhoff,James J.; Elghanian,Robert; Taton,Thomas Andrew, Nanoparticles having oligonucleotides attached thereto and uses therefor.
  120. Mirkin,Chad A.; Letsinger,Robert L.; Mucic,Robert C.; Storhoff,James J.; Elghanian,Robert; Taton,Thomas Andrew; Garimella,Viswanadham; Li,Zhi; Park,So Jung; Lu,Gang, Nanoparticles having oligonucleotides attached thereto and uses therefor.
  121. Mirkin,Chad A.; Letsinger,Robert L.; Park,So Jung, Nanoparticles having oligonucleotides attached thereto and uses therefor.
  122. Park,So Jung; Taton,Thomas Andrew; Mirkin,Chad A., Nanoparticles having oligonucleotides attached thereto and uses therefor.
  123. Mirkin, Chad A.; Letsinger, Robert L.; Mucic, Robert C.; Storhoff, James J.; Elghanian, Robert; Taton, Thomas A., Nanoparticles having oligonucleotides attached thereto and uses thereof.
  124. Mirkin,Chad A.; Nguyen,SonBinh T., Nanoparticles with polymer shells.
  125. Mirkin,Chad A.; Cao,Yun Wei; Jin,Rongchao, Non-alloying core shell nanoparticles.
  126. Mirkin,Chad A.; Cao,Yun Wei; Jin,Rongchao, Non-alloying core shell nanoparticles.
  127. Mirkin,Chad A.; Cao,Yun Wei; Jin,Rongchao, Non-alloying core shell nanoparticles.
  128. Akhavan-Tafti, Hashem, Nonseparation assay methods.
  129. Akhavan-Tafti, Hashem, Nonseparation assay methods.
  130. Akhavan-Tafti, Hashem, Nonseparation assay methods.
  131. Khanna Pyare (Mountain View CA) Ullman Edwin F. (Atherton CA), Novel alkyl substituted fluorescent compounds and polyamino acid conjugates.
  132. Law Say-Jong, Nucleophilic polysubstituted aryl acridinium ester conjugates and syntheses thereof.
  133. Law Say-Jong (Westwood MA), Nucleophilic polysubstituted aryl acridinium ester conjugates and syntheses thereof.
  134. Carr Stuart William,GB3 ; Pickup Karen Marie,GB3 ; Smith Philippa Margaret,GB3 ; Schilling Kurt Matthew,GB3, Oral care compositions.
  135. , Phenanthridinium ester as a labelling compound in luminometric immunoassay.
  136. Pease John S. ; Kirakossian Hrair ; Wagner Daniel B. ; Ullman Edwin F., Photoactivatable chemiluminescent matrices.
  137. Akiyoshi Yutaka (Tokyo JPX) Kobayashi Shinzo (Tokyo JPX) Kakimi Fujio (Shizuoka JPX) Matsukawa Hiroharu (Shizuoka JPX), Process for preparing microcapsule reagents for immunological response.
  138. Patel, Rajesh; Kurn, Nurith, Quantitative determination of nucleic acid amplification products.
  139. Rajesh Patel ; Nurith Kurn, Quantitative determination of nucleic acid amplification products.
  140. Clark Scott M., Reversible flow chromatographic binding assay.
  141. Clark Scott M., Reversible flow chromatographic binding assay.
  142. Clark Scott M., Reversible flow chromatographic binding assay system, kit, and method.
  143. Wagner Daniel B. (Raleigh NC) Baffi Robert A. (Devaulf PA), Sac having a marker linked thereto.
  144. Watkins, Michael; Prestigiacomo, Tony; Binder, Steven; Tan, Woei, Solid phase immobilization of phospholipids and cofactor proteins via covalent attachment.
  145. Considine,John Leo; Daigneault,Sylvain; Chew,Warren; Iera,Silvio; Duncan,Scott Mason; Ren,Jianxin, Synthesis of 4-(amino)-2-butenoyl chlorides and their use in the preparation of 3-cyano quinolines.
  146. Huang Leaf (Knoxville TN), Target-sensitive immunoliposomes- preparation and characterization.
  147. Geho W. Blair (533 Beechwood St. Wooster OH 44691) Lau John R. (1634 Morgan St. Wooster OH 44691), Therapy by vesicle delivery to the hydroxyapatite of bone.
  148. Martin Frank J. (San Francisco CA) Papahadjopoulos Demetrios P. (Lafayette CA) Hubbell Wayne L. (Orinda CA), Thiol reactive liposomes.
  149. Rabindran,Sridhar K.; Gibbons, Jr.,James J., Treatment of neoplasms with CCI-779/EKB-569 combination.
  150. Wagner Daniel B. (Raleigh NC) Baffi Robert A. (Devaulf PA), Vesicle including a metal marker for use in an assay.
  151. Wagner Daniel B. (Raleigh NC), Vesticles and use thereof in an enzyme assay.

활용도 분석정보

상세보기
다운로드
내보내기

활용도 Top5 특허

해당 특허가 속한 카테고리에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로